Exact Mass: 698.5485

Exact Mass Matches: 698.5485

Found 136 metabolites which its exact mass value is equals to given mass value 698.5485, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

DG(19:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-Hydroxy-3-(nonadecanoyloxy)propan-2-yl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/19:0/0:0)

(2S)-3-Hydroxy-2-(nonadecanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(19:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-2-Hydroxy-3-(nonadecanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/19:0)

(2S)-2-Hydroxy-3-(nonadecanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-Hydroxy-3-(nonadecanoyloxy)propan-2-yl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/19:0/0:0)

(2S)-3-Hydroxy-2-(nonadecanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(19:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-2-Hydroxy-3-(nonadecanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/19:0)

(2S)-2-Hydroxy-3-(nonadecanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(19:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-Hydroxy-3-(nonadecanoyloxy)propan-2-yl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/19:0/0:0)

(2S)-3-Hydroxy-2-(nonadecanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(19:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-2-Hydroxy-3-(nonadecanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/19:0)

(2S)-2-Hydroxy-3-(nonadecanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(19:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(nonadecanoyloxy)propan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/19:0/0:0)

(2S)-3-Hydroxy-2-(nonadecanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(19:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-2-Hydroxy-3-(nonadecanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(19:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/19:0)

(2S)-2-Hydroxy-3-(nonadecanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(19:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-3-Hydroxy-2-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propyl nonadecanoic acid

C44H74O6 (698.5485)

DG(19:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/19:0/0:0)

(2S)-1-Hydroxy-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propan-2-yl nonadecanoic acid

C44H74O6 (698.5485)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(19:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-2-Hydroxy-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propyl nonadecanoic acid

C44H74O6 (698.5485)

DG(19:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/19:0)

(2S)-2-Hydroxy-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propyl nonadecanoic acid

C44H74O6 (698.5485)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propan-2-yl (5Z,7Z,10Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(i-19:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-19:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-19:0/0:0)

(2S)-3-hydroxy-2-[(17-methyloctadecanoyl)oxy]propyl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C44H74O6 (698.5485)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(i-19:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-19:0)

(2S)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propan-2-yl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(i-19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-19:0/0:0)

(2S)-3-Hydroxy-2-[(17-methyloctadecanoyl)oxy]propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(i-19:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-19:0)

(2S)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-hydroxy-3-[(17-methyloctadecanoyl)oxy]propan-2-yl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C44H74O6 (698.5485)

DG(i-19:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-19:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-19:0/0:0)

(2S)-3-Hydroxy-2-[(17-methyloctadecanoyl)oxy]propyl (4Z,7Z,10Z,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-2-hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C44H74O6 (698.5485)

DG(i-19:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-19:0)

(2S)-2-hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propan-2-yl (4Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(i-19:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-19:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-19:0/0:0)

(2S)-3-Hydroxy-2-[(17-methyloctadecanoyl)oxy]propyl (4Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(i-19:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-19:0)

(2S)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C44H74O6 (698.5485)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-3-Hydroxy-2-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propyl 17-methyloctadecanoic acid

C44H74O6 (698.5485)

DG(i-19:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-19:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-19:0/0:0)

(2S)-1-Hydroxy-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propan-2-yl 17-methyloctadecanoic acid

C44H74O6 (698.5485)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-19:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-2-Hydroxy-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propyl 17-methyloctadecanoic acid

C44H74O6 (698.5485)

DG(i-19:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-19:0)

(2S)-2-Hydroxy-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propyl 17-methyloctadecanoic acid

C44H74O6 (698.5485)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

4-hydroxy-3-methyl-5-[(2e,6e,10z,14r)-11,14,15-trihydroxy-3,7,15-trimethylhexadeca-2,6,10-trien-1-yl]phenyl octadecanoate

C44H74O6 (698.5485)